.beta.-Alanine:pyruvate aminotransferase

Endpoint summary

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Additional information

Justification for selection of acute toxicity – oral endpoint
Data from acute and subchronic oral toxicity studies provide evidence that enzymes are of very low toxicological activity. Typically, the derived NOAEIn general, enzymes are of very low toxicity due to ready biodegradability and very low bioavailability. In traditional acute toxicity testing, mortality has been the endpoint. However, because enzymes show very low toxicity, extremely high doses that are far above human exposure levels typically have been applied. Therefore, acute toxicity studies are not considered to provide appropriate knowledge and are as such not a relevant test system for enzymes. *
*Enzymes REACH Consortium, ERC Data waiving argumentation for technical enzymes